Naproxen Sodium
NDC 79903-232, Naproxen Sodium, tablet, film coated, from WALMART INC..
- Product NDC
- 79903-232
- Status
- Listed
- Labeler
- WALMART INC.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA205497
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/79903-232 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NAPROXEN SODIUM220 mg/1
Pharmacologic classes
Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 79903-232-90 | 79903023290 | 1 BOTTLE in 1 CARTON (79903-232-90) / 90 TABLET, FILM COATED in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 79903-232 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/79903-232 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 79903-232. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.